Cargando…

Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy

AIMS: Peripartum cardiomyopathy (PPCM) is a systolic left ventricular dysfunction developing in the peripartum phase in previously healthy women. Relaxin-2 is a pregnancy hormone with potential beneficial effects in heart failure patients. We evaluated Relaxin-2 as a potential diagnostic marker and/...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nonhoff, Justus, Ricke-Hoch, Melanie, Mueller, Mirco, Stapel, Britta, Pfeffer, Tobias, Kasten, Martina, Scherr, Michaela, von Kaisenberg, Constantin, Bauersachs, Johann, Haghikia, Arash, Hilfiker-Kleiner, Denise
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412020/ https://www.ncbi.nlm.nih.gov/pubmed/28453725 http://dx.doi.org/10.1093/cvr/cvw245

Ejemplares similares

Peripartum cardiomyopathy: current management and future perspectives
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2015)

Perhexiline treatment improves toxic effects of β‐adrenergic receptor stimulation in experimental peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2021)

Characterization of peripartum cardiomyopathy by cardiovascular magnetic resonance imaging
por: Haghikia, Arash, et al.
Publicado: (2015)

STAT3 regulation of and by microRNAs in development and disease
por: Haghikia, Arash, et al.
Publicado: (2012)

Cabergoline treatment promotes myocardial recovery in peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Low STAT3 expression sensitizes to toxic effects of β-adrenergic receptor stimulation in peripartum cardiomyopathy
por: Stapel, Britta, et al.
Publicado: (2017)

High prevalence of reduced fertility and use of assisted reproductive technology in a German cohort of patients with peripartum cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2022)

Increased Cancer Prevalence in Peripartum Cardiomyopathy
por: Pfeffer, Tobias J., et al.
Publicado: (2019)

Peripartum cardiomyopathy
por: Koenig, T., et al.
Publicado: (2018)

Assessment of major mental disorders in a German peripartum cardiomyopathy cohort
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

Data on left ventricular expression of STAT3 and AKT in transgenic mouse models with B16F10 melanoma
por: Pietzsch, Stefan, et al.
Publicado: (2019)

Prognostic implication of right ventricular involvement in peripartum cardiomyopathy: a cardiovascular magnetic resonance study
por: Haghikia, Arash, et al.
Publicado: (2015)

Rationale and design of a randomized, controlled multicentre clinical trial to evaluate the effect of bromocriptine on left ventricular function in women with peripartum cardiomyopathy
por: Haghikia, Arash, et al.
Publicado: (2015)

Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy
por: Haghikia, A., et al.
Publicado: (2013)

Outcome in German and South African peripartum cardiomyopathy cohorts associates with medical therapy and fibrosis markers
por: Azibani, Feriel, et al.
Publicado: (2020)

Bromocriptine treatment in patients with peripartum cardiomyopathy and right ventricular dysfunction
por: Haghikia, Arash, et al.
Publicado: (2018)

Bromocriptine for the treatment of peripartum cardiomyopathy: a multicentre randomized study
por: Hilfiker-Kleiner, Denise, et al.
Publicado: (2017)

Increased prostaglandin-D(2) in male STAT3-deficient hearts shifts cardiac progenitor cells from endothelial to white adipocyte differentiation
por: Stelling, Elisabeth, et al.
Publicado: (2020)

Neuraminidase-1 promotes heart failure after ischemia/reperfusion injury by affecting cardiomyocytes and invading monocytes/macrophages
por: Heimerl, Maren, et al.
Publicado: (2020)

Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects
por: Pietzsch, Stefan, et al.
Publicado: (2021)

Human iPSC-Derived Cardiomyocytes of Peripartum Patients With Cardiomyopathy Reveal Aberrant Regulation of Lipid Metabolism
por: Hoes, Martijn F., et al.
Publicado: (2020)

Risk for life-threatening arrhythmia in newly diagnosed peripartum cardiomyopathy with low ejection fraction: a German multi-centre analysis
por: Duncker, David, et al.
Publicado: (2017)

Breastfeeding in Patients With Heart Failure: Lack of Evidence and Consensus
por: Koenig, Tobias, et al.
Publicado: (2019)

Chemotherapy-Free Targeted Anti-BCR-ABL+ Acute Lymphoblastic Leukemia Therapy May Benefit the Heart
por: Kirchhoff, Hanna, et al.
Publicado: (2022)

Serelaxin treatment reverses vascular dysfunction and left ventricular hypertrophy in a mouse model of Type 1 diabetes
por: Ng, Hooi Hooi, et al.
Publicado: (2017)

Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports
por: Meyer, Gerd Peter, et al.
Publicado: (2010)

Differences in the renal antifibrotic signaling of serelaxin and zaprinast
por: Wetzl, Veronika, et al.
Publicado: (2015)

Complete recovery of fulminant peripartum cardiomyopathy on mechanical circulatory support combined with high‐dose bromocriptine therapy
por: Horn, Patrick, et al.
Publicado: (2017)

Small molecule-mediated refolding and activation of myosin motor function
por: Radke, Michael B, et al.
Publicado: (2014)

Optimized induction of mitochondrial apoptosis for chemotherapy-free treatment of BCR-ABL+acute lymphoblastic leukemia
por: Scherr, Michaela, et al.
Publicado: (2018)

Emerging translational approaches to target STAT3 signalling and its impact on vascular disease
por: Dutzmann, Jochen, et al.
Publicado: (2015)

Low-dose Erythropoietin reduces risk of heart failure induced by anti-cancer therapy
por: Hoch, Melanie, et al.
Publicado: (2011)

Macrophage Mineralocorticoid Receptor Is a Pleiotropic Modulator of Myocardial Infarct Healing
por: Fraccarollo, Daniela, et al.
Publicado: (2019)

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease
por: Ricke-Hoch, Melanie, et al.
Publicado: (2021)

Serelaxin Elicits Bronchodilation and Enhances β-Adrenoceptor-Mediated Airway Relaxation
por: Lam, Maggie, et al.
Publicado: (2016)

Serelaxin increases the antifibrotic action of rosiglitazone in a model of hepatic fibrosis
por: Bennett, Robert G, et al.
Publicado: (2017)

Serelaxin improves cardiac and renal function in DOCA-salt hypertensive rats
por: Wang, Dong, et al.
Publicado: (2017)

Serelaxin Alleviates Fibrosis in Thyroid-Associated Ophthalmopathy via the Notch Pathway
por: Sun, Anqi, et al.
Publicado: (2023)

Behavioral pathway to a broken heart: The link between adverse childhood experiences, depression, physical exercise and cardiovascular health
por: Bertele, Sebastian, et al.
Publicado: (2022)

Common genetic predisposition for heart failure and cancer
por: Pfeffer, Tobias J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ard0bta361d6sgvuhh9vv7mpim